Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $523.3 million.

  • Maravai Lifesciences Holdings' Non-Current Assets fell 1265.08% to $523.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 2401.38%. This contributed to the annual value of $579.1 million for FY2024, which is 2646.73% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Non-Current Assets stood at $523.3 million for Q3 2025, which was down 1265.08% from $537.2 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non-Current Assets peaked at $1.6 billion during Q3 2023, and registered a low of $523.3 million during Q3 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Non-Current Assets value was $956.8 million (recorded in 2021), while the average stood at $1.0 billion.
  • In the last 5 years, Maravai Lifesciences Holdings' Non-Current Assets surged by 5375.26% in 2022 and then plummeted by 6175.9% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non-Current Assets (Quarter) stood at $1.2 billion in 2021, then grew by 21.74% to $1.4 billion in 2022, then tumbled by 45.1% to $787.5 million in 2023, then fell by 26.47% to $579.1 million in 2024, then decreased by 9.63% to $523.3 million in 2025.
  • Its Non-Current Assets stands at $523.3 million for Q3 2025, versus $537.2 million for Q2 2025 and $583.5 million for Q1 2025.